Neurotech

eye with dollar sign
Pharma

Alcon acquires Neurotech and its approved Encelto for $550M

Alcon says it will now help take Encelto global and leverage Neurotech's technology to develop more convenient ocular therapies.
Donavyn Coffey Oct 21, 2026 10:56am
Youtubes front page on a laptop screen but the photo is at an angle obscuring most of the the thumbnails

Neurotech turns to YouTube for rare eye disorder campaign

Jun 3, 2026 9:32am
Eye eye anatomy eye disease vision disorder ophthalmology

Neurotech nabs first nod for eye disease cell therapy implant

Mar 10, 2025 9:50am
eye eyeball retinal diseases

Vision loss cell therapy implant hits primary goals in phase 3

Nov 8, 2022 7:45am